Mirova US LLC Has $1.72 Million Stock Position in Colgate-Palmolive Company $CL

Mirova US LLC increased its position in Colgate-Palmolive Company (NYSE:CL) by 17.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,880 shares of the company’s stock after purchasing an additional 2,769 shares during the quarter. Mirova US LLC’s holdings in Colgate-Palmolive were worth $1,716,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Vanguard Group Inc. grew its position in shares of Colgate-Palmolive by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 81,758,257 shares of the company’s stock worth $7,660,749,000 after buying an additional 455,198 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after buying an additional 5,269,140 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after buying an additional 2,045,191 shares during the period. Deutsche Bank AG grew its position in shares of Colgate-Palmolive by 3.7% during the 1st quarter. Deutsche Bank AG now owns 7,176,598 shares of the company’s stock worth $672,447,000 after buying an additional 253,604 shares during the period. Finally, Ameriprise Financial Inc. grew its position in shares of Colgate-Palmolive by 2.6% during the 1st quarter. Ameriprise Financial Inc. now owns 6,976,654 shares of the company’s stock worth $653,761,000 after buying an additional 177,833 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CL. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Morgan Stanley decreased their target price on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research report on Thursday, September 25th. Piper Sandler began coverage on Colgate-Palmolive in a research report on Friday. They set a “neutral” rating and a $84.00 target price for the company. Finally, The Goldman Sachs Group cut their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Seven research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $94.83.

Colgate-Palmolive Trading Up 2.0%

NYSE:CL opened at $78.99 on Wednesday. Colgate-Palmolive Company has a fifty-two week low of $77.09 and a fifty-two week high of $102.61. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market capitalization of $63.84 billion, a PE ratio of 22.19, a price-to-earnings-growth ratio of 4.03 and a beta of 0.34. The business’s 50-day simple moving average is $82.95 and its 200-day simple moving average is $88.15.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.